Badrul Chowdhury

Insider profile

Currently holds positions in Savara Inc and Proteostasis Therapeutics Inc

Performance

Overall performance
3.1
Performance over holding periods
3.1
30 days 90 days 120 days
Average return 25% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
1 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Chief Medical Officer Savara Inc Nov. 18, 2019 -
Director Proteostasis Therapeutics Inc May 12, 2019 -
Badrul Chowdhury's trades of Savara Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
US Savara Inc (SVRA)
Transaction date
Purchase
Price
10.10
Quantity 24,272 +41.8%
Value US$3,761,143
US Savara Inc (SVRA)
Transaction date
Planned sale
Price
305.02
Quantity 33,447 -37.2%
Value US$3,038,125
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2021-12-09 2021-12-09
US Savara Inc (SVRA)
B Purchase
24,272 +41.8%
10.10
US$3,761,143 		24,272 +41.8% 10.10 US$3,761,143
2021-05-17 2021-05-17
US Savara Inc (SVRA)
PlS Planned sale
33,447 -37.2%
305.02
US$3,038,125 		33,447 -37.2% 305.02 US$3,038,125